14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 31 May 2024

Trading levels for XNCR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.90 3.05 %
R2 23.56 1.60 %
R1 23.35 0.702 %
Current price: 23.19
Support S1 22.68 -2.20 %
S2 22.47 -3.09 %
S3 22.14 -4.54 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 23.93 3.19 %
R2 23.75 2.41 %
R1 23.63 1.90 %
Current price 23.19
Support S1 23.09 -0.431%
S2 22.85 -1.47%
S3 22.46 -3.15%

XNCR Predictions History

5 years ago
NameNotImportant predicted that XNCR for 2019-05-06 is going $33.69 (3.03%)

5 years ago
NameNotImportant predicted that XNCR for 2019-04-29 is going $32.20 (2.06%)

5 years ago
NameNotImportant predicted that XNCR for 2019-04-24 is going $31.44 (-1.23%)

5 years ago
NameNotImportant predicted that XNCR for 2019-04-23 is going $30.92 (-5.18%)

5 years ago
NameNotImportant predicted that XNCR for 2019-04-22 is going $31.99 (2.01%)

6 years ago
Jorge.Burke.Jr..23383 predicted that XNCR for 2018-04-12 is going $30.95 (5.09%)

Rank:

6 years ago
abhi predicted that XNCR for 2018-04-12 is going $31.28 (6.21%)

Rank:
Click to get the best stock tips daily for free!

About Xencor

Xencor Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with r... XNCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT